Many skin conditions appear differently in melanated skin, leading to misdiagnosis and poor treatment. Understanding these ...
Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...
Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.
The following is a summary of “Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory ...
The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...
Apple cider vinegar is fermented juice made from apples. It may be useful in blood sugar management, weight loss, and ...
Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...
A new medicine, Nenolizumab, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat two skin conditions ...
Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedi ...
An AI-enabled wearable sensor with vibratory feedback significantly reduces nocturnal scratching in atopic dermatitis, ...
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...
These are the first approvals of nemolizumab from countries within the Access Consortium framework, with regulatory review processes ongoing in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback